Volume 10, Number 9—September 2004
Synopsis
Laboratory Exposures to Staphylococcal Enterotoxin B
Table
Signs and symptoms | Event 1a (1963) N = 2 | Event 2b (1963) N = 4 | Event 3 (1964) N = 10 | Total (%) |
---|---|---|---|---|
Generalized | ||||
Fever | 2 | 4 | 9 | 15/16 (93.7) |
Chills | 2 | 2 | 9 | 13/16 (81.3) |
Headache | 2 | 2 | 9 | 13/16 (81.3) |
Myalgia | 2 | 1 | 8 | 11/16 (68.7) |
Fatigue | NDc | 2 | 8 | 10/14 (71.4) |
Malaise | ND | 2 | 7 | 9/14 (64.3) |
Lower respiratory | ||||
Cough | 2 | 3 | 10 | 15/16 (93.7) |
Dyspnea | 2 | 2 | 4 | 8/16 (50.0) |
Retrosternal or chest pain | ND | 3 | 5 | 8/14 (57.1) |
Wheezing | 1 | 0 | 1 | 2/16 (12.5) |
Gastrointestinal | ||||
Nausea | 2 | 4 | 6 | 12/16 (75.0) |
Vomiting | 2 | 3 | 4 | 9/16 (56.3) |
Anorexia | 2 | 2 | 5 | 9/16 (56.3) |
Abdominal cramps | ND | 1 | 2 | 3/14 (21.4) |
Diarrhead | 2 | 0 | 0 | 2/16 (12.5) |
Gas | ND | 0 | 1 | 1/14 (7.1) |
Hepatitis | 0 | 0 | 1 | 1/14 (7.1) |
Upper respiratory | ||||
Pharyngeal injection | ND | 2 | 3 | 5/14 (35.7) |
Rhinorrhea, postnasal drip, or sinus congestion | ND | 2 | 2 | 4/14 (28.6) |
Sore throat | ND | 1 | 2 | 3/14 (21.4) |
Otitis | ND | 1 | 1 | 2/14 (14.3) |
Hoarseness | ND | 0 | 1 | 1/14 (7.1) |
Other | ||||
Conjunctival injection | ND | 2 | 2 | 4/14 (28.6) |
Burning eyes | ND | 0 | 1 | 1/14 (7.1) |
Flushed face | ND | 1 | 0 | 1/14 (7.1) |
aOnly occupational summary reports reviewed (medical records not available).
bNo records available on the one nonhospitalized symptomatic person.
cND, no data.
dLoose stools noted in one person in the second and the third events.
Page created: March 29, 2011
Page updated: March 29, 2011
Page reviewed: March 29, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.